So far, WT1 has been incriminated as a necessary contributor to KRAS-driven oncogenesis, demonstrating decisive regulatory roles regarding tumor cell responses (i.e., proliferation versus senescence) downstream of KRAS oncogenic signaling. The gene discussed is KRAS; the disease is neoplasm.